LOX Fails to Substitute for RANKL in Osteoclastogenesis

Inhibition of the TNF Family Cytokine RANKL Prevents Autoimmune Inflammation in the Central Nervous System

(2015) Matteo M. Guerrini et al.   IMMUNITY

The hypoxic cancer secretome induces pre-metastatic bone lesions through lysyl oxidase

(2015) Thomas R. Cox et al.   NATURE

Role of reactive oxygen species in angiotensin II: induced receptor activator of nuclear factor-κB ligand expression in mouse osteoblastic cells

(2014) Yanqiu Zhang et al.   MOLECULAR AND CELLULAR BIOCHEMISTRY

Investigation of osteoclastogenic signalling of the RANKL substitute LIGHT

(2013) F. Hemingway et al.   EXPERIMENTAL AND MOLECULAR PATHOLOGY

New insights into osteoclastogenic signaling mechanisms

(2012) Tomoki Nakashima et al.   TRENDS IN ENDOCRINOLOGY AND METABOLISM

Human mesenchymal stromal cells express CD14 cross-reactive epitopes

(2011) Gregor A. Pilz et al.   CYTOMETRY PART A

RANKL-independent human osteoclast formation with APRIL, BAFF, NGF, IGF I and IGF II

(2010) F. Hemingway et al.   BONE

RANKL Is Necessary and Sufficient to Initiate Development of Antigen-Sampling M Cells in the Intestinal Epithelium

(2009) K. A. Knoop et al.   JOURNAL OF IMMUNOLOGY

The Mechanism of Osteoclast Differentiation Induced by IL-1

(2009) J. H. Kim et al.   JOURNAL OF IMMUNOLOGY

Central control of fever and female body temperature by RANKL/RANK

(2009) Reiko Hanada et al.   NATURE